Evidence map›Paper›PMID 26952808›Full record

ArticleFree radical biology & medicine2016

Glutathione-deficient Plasmodium berghei parasites exhibit growth delay and nuclear DNA damage.

Vivian Padín-Irizarry, Emilee E Colón-Lorenzo, Joel Vega-Rodríguez, María Del R Castro, Ricardo González-Méndez, Sylvette Ayala-Peña, Adelfa E Serrano

Open access · hybridAbstract read
In one paragraph

Article in Free radical biology & medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vivian Padín-IrizarryDepartment of Microbiology and Medical Zoology, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico.
Emilee E Colón-LorenzoDepartment of Microbiology and Medical Zoology, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico.
Joel Vega-RodríguezDepartment of Microbiology and Medical Zoology, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico.
María Del R CastroDepartment of Pharmacology and Toxicology, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico.
Ricardo González-MéndezDepartment of Radiological Sciences, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico.
Sylvette Ayala-PeñaDepartment of Pharmacology and Toxicology, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico.
Adelfa E SerranoDepartment of Microbiology and Medical Zoology, University of Puerto Rico, School of Medicine, San Juan 00936-5067, Puerto Rico. Electronic address: adelfa.serrano@upr.edu.
University of Puerto Rico, Medical Sciences Campus · PRUniversity of Puerto Rico System · PR

Funding

SUPPLEMENT FOR RENOVATION OF ANIMAL FACILITIES AT INSTITUTE OF NEUROBIOLOGYG12RR003051 · NCRR · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI ESPINO, ANA M · 1986 to 2011
$28.1M
UPR--MEDICAL SCIENCES CAMPUS, MBRS PROGRAMS06GM008224 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI SILVA, WALTER I · 1989 to 2008
$28.0M
RISE Option III: MBRS RISE at the UPR Medical Sciences CampusR25GM061838 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CADILLA, CARMEN LYDIA · 2000 to 2021
$25.5M
TRANSLATIONAL PROTEOMICS CENTERG12MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 2012 to 2016
$11.0M
Bioinformatics Programs at Minority InstitutionsT36GM095335 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI ROPELEWSKI, ALEXANDER J · 2011 to 2015
$3.2M
Role of Ape1 in Huntington's Disease NeurodegenerationSC1NS095380 · NINDS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI AYALA-PENA, SYLVETTE · 2015 to 2019
$1.6M
NCRR NIH HHS G12 RR003051NIGMS NIH HHS R25 GM061838NIGMS NIH HHS S06 GM008224NIGMS NIH HHS T36 GM095335NIMHD NIH HHS G12 MD007600NINDS NIH HHS SC1 NS095380
6 · The paper itself

Abstract

Plasmodium parasites are exposed to endogenous and exogenous oxidative stress during their complex life cycle. To minimize oxidative damage, the parasites use glutathione (GSH) and thioredoxin (Trx) as primary antioxidants. We previously showed that disruption of the Plasmodium berghei gamma-glutamylcysteine synthetase (pbggcs-ko) or the glutathione reductase (pbgr-ko) genes resulted in a significant reduction of GSH in intraerythrocytic stages, and a defect in growth in the pbggcs-ko parasites. In this report, time course experiments of parasite intraerythrocytic development and morphological studies showed a growth delay during the ring to schizont progression. Morphological analysis shows a significant reduction in size (diameter) of trophozoites and schizonts with increased number of cytoplasmic vacuoles in the pbggcs-ko parasites in comparison to the wild type (WT). Furthermore, the pbggcs-ko mutants exhibited an impaired response to oxidative stress and increased levels of nuclear DNA (nDNA) damage. Reduced GSH levels did not result in mitochondrial DNA (mtDNA) damage or protein carbonylations in neither pbggcs-ko nor pbgr-ko parasites. In addition, the pbggcs-ko mutant parasites showed an increase in mRNA expression of genes involved in oxidative stress detoxification and DNA synthesis, suggesting a potential compensatory mechanism to allow for parasite proliferation. These results reveal that low GSH levels affect parasite development through the impairment of oxidative stress reduction systems and damage to the nDNA. Our studies provide new insights into the role of the GSH antioxidant system in the intraerythrocytic development of Plasmodium parasites, with potential translation into novel pharmacological interventions.

Indexed as

AnimalsAntioxidantsCell NucleusDNA DamageDNA, MitochondrialGene Knockout TechniquesGlutamate-Cysteine LigaseGlutathioneGlutathione ReductaseLife Cycle StagesMalariaOxidative StressPlasmodium bergheiThioredoxinsAntioxidantsDNA, MitochondrialGlutamate-Cysteine LigaseGlutathioneGlutathione ReductaseThioredoxinsDNA damageGlutathioneGrowth delayMalariaOxidative stressPlasmodium bergheiProtein carbonylations

Identifiers

PMID26952808
PMCPMC4934901
OpenAlexW2290096267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.